2016
DOI: 10.1016/j.clindermatol.2015.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Ocular changes induced by drugs commonly used in dermatology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 69 publications
0
4
0
Order By: Relevance
“…Ocular reactions to prolonged use of systemic retinoid therapy likewise include corneal opacities, disorders of refraction, and alterations in retina and optic nerve. 22 , 23 The manifestations of DSM in onchocerciasis include areas of complete pigment loss (ie, vitiligo) with islands of normal skin pigment (“leopard skin”). Consistent with the hypothesis, mice homozygous for the vitiligo (Mitf-vit) mutation experience progressive degeneration of the retina as well as uneven pigmentation of the retinal pigment epithelium (RPE), associated with significantly increased retinyl ester concentrations in eyes and liver.…”
Section: Discussionmentioning
confidence: 99%
“…Ocular reactions to prolonged use of systemic retinoid therapy likewise include corneal opacities, disorders of refraction, and alterations in retina and optic nerve. 22 , 23 The manifestations of DSM in onchocerciasis include areas of complete pigment loss (ie, vitiligo) with islands of normal skin pigment (“leopard skin”). Consistent with the hypothesis, mice homozygous for the vitiligo (Mitf-vit) mutation experience progressive degeneration of the retina as well as uneven pigmentation of the retinal pigment epithelium (RPE), associated with significantly increased retinyl ester concentrations in eyes and liver.…”
Section: Discussionmentioning
confidence: 99%
“… 1 There are also reports that GC causes central serous chorioretinopathy, ptosis, mydriasis, and exophthalmos. 1 , 22 , 31 …”
Section: Ophthalmological Changesmentioning
confidence: 99%
“…Cataract, usually posterior subcapsular, is associated with chronic use of systemic GCs, and its incidence can reach 58%. 22 , 31 There is no well-established correlation between cataract risk and dose/duration of GC treatment, but there seems to be an increased susceptibility for some individuals. 31 …”
Section: Ophthalmological Changesmentioning
confidence: 99%
See 1 more Smart Citation